Clinical-stage pharmaceutical developer of transdermal loading into circulating blood cells for targeted anti-inflammatory and analgesic therapies that bypass oral bioavailability and provide a needle-free alternative. Portfolio: a patented topical transdermal delivery system, a curcumin-based lead candidate in Phase 1 for sickle cell disease and osteoarthritis, and curcumin-linked targeted cancer therapeutics to improve efficacy and reduce side effects.